Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 1,337.2 | 610.2 | 92.4 |
| Revenue growth | 119.1% | 560.3% | |
| Cost of goods sold | 1,336.3 | 553.7 | 39.8 |
| Gross profit | 0.9 | 56.5 | 52.6 |
| Gross margin | 0.1% | 9.3% | 56.9% |
| Selling, general and administrative | 714.7 | 314.9 | 210.6 |
| Research and development | 232.9 | 183.8 | 34.4 |
| EBIT | -994.8 | -440.5 | -191.0 |
| EBIT margin | -74.4% | -72.2% | -206.7% |
| Pre-tax income | -1,007.1 | -471.3 | -196.0 |
| Income taxes | 0.3 | 13.5 | 2.0 |
| Net income | -1,007.5 | -484.9 | -198.0 |
| Net margin | -75.3% | -79.5% | -214.2% |
| |
| Diluted EPS | ($4.39) | ($2.40) | ($0.99) |
| Shares outstanding (diluted) | 229.5 | 202.0 | 200.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|